AbelsonTaylor | Agency Profile, Contacts, AOR, Client Relationships
- Main Telephone
- (312) 894-5500
Sample of Related Brands
|Dale T.||President & Chief Executive Officer||IL|
|Keith S.||Chief Financial Officer||IL|
|Robert W.||Creative Director||IL|
|Steven H.||Associate Creative Director||IL|
Future Possibility: Astellas Pharmaceuticals taps new senior director of product, brand communications (Score 22)
As part of a larger communications team restructuring, pharmaceutical company Astellas has just appointed Colin McBean as senior director of US product and brand communications, effective April 30. With director experience with companies such as Archer Daniels Midland Company, Baxalta, Abbott, and Chrysler, McBean will manage Astellas's brand and corporate reputation in the States. The company also recently hired Gary Thal as VP, and it is looking too build recognition of its oncology segment.
Astellas's top spending period tends to be Q1-Q3, so sellers should reach out soon to secure revenue.
According to iSpot, the company has spent $30,647 so far this year on national TV ads, targeting various shows on the Science Channel (see targeting right). Astellas has already nearly halved last year's total spend of $66,887, which was a significant decrease from $543,338 in 2016.
Pathmatics reports a year-to-date (YTD) digital spend of $848,100, with 96% of ads placed direct and through Google Ads on sites including healthgrades.com, lifescript.com, psychologytoday.com, weather.com, dictionary.com, and opposingviews.com. Astellas's total 2017 spend of $2.8 million grew from $1.9 million in 2016.
Agency & martech readers - as you're well aware, an outside decision maker hire is the number one sign of a possible future agency review, so reach out soon to get on McBean's radar. Pitch high ROI strategies for engagement among boomers. Media buying and planning is currently handled by Abelson-Taylor leading creative work.